Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Cough and cold medicines recalled by Novartis

  • Comment

A drug alert has been issued over certain batches of Tixylix cough and cold medicines from consumers.

The Medicines and Healthcare products Regulatory Agency said Novartis Consumer Health Ltd had been made aware of a possible fault in the manufacturing process of the tamper seal that might result in small pieces of plastic being found in the liquid medicines.

The MHRA added that there was currently no evidence of patients having problems as a result of the fault, but they are being asked to return the following medicines as a precautionary measure.

The recalled batches of the Tixylix medicines are:

• Tixylix Toddler Syrup 100ml (Glycerol) PL 00030/0150

• Tixylix Toddler Syrup 150ml (Glycerol) PL 00030/0150

• Tixylix Baby Syrup 100ml (Glycerol) PL 00030/0150

• Tixylix Blackcurrant Flavour Syrup 100ml (Glycerol) PL 00030/0150

• Tixylix Chesty Cough 100ml (Guaifenesin) PL 00030/0082

Adam Burgess, the MHRA’s head of defective medicines reporting centre, said: “This is a precautionary recall.”


Read full drug alert


  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs